Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes
- 1 January 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 47 (1), 124-131
- https://doi.org/10.1007/s00125-003-1276-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived FactorPublished by Elsevier BV ,2002
- Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in ratsDiabetologia, 2001
- Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416.2000
- Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibitionProceedings of the National Academy of Sciences of the United States of America, 1999
- Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal AntibodyToxicologic Pathology, 1999
- Structure and Ligand Binding Determinants of the Recombinant Kringle 5 Domain of Human Plasminogen,Biochemistry, 1998
- The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.1996
- Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Oxygen-induced retinopathy in the mouse.1994